Articles From: Evoke Pharma Announces the Completion of Enrollment in Its Thorough ECG Study for EVK-001 to Exact Sciences Reports Third-Quarter 2014 Financial Results


SOLANA BEACH, Calif., Sept.
Sign-up for Evoke Pharma Announces the Completion of Enrollment in Its Thorough ECG Study for EVK-001 investment picks
SOLANA BEACH, Calif., Nov.
Sign-up for Evoke Pharma Reports Third Quarter 2014 Results investment picks
SOLANA BEACH, Calif., Nov.
Sign-up for Evoke Pharma Schedules Webcast and Conference Call for Third Quarter 2014 Financial Results investment picks
SOLANA BEACH, Calif., Nov.
Sign-up for Evoke Pharma to Present at LD Micro Conference investment picks
SOLANA BEACH, Calif., Sept.
Sign-up for Evoke Pharma to Present at the Aegis Capital Corp. 2014 Healthcare & Technology Conference investment picks
SOLANA BEACH, Calif., Dec.
Sign-up for Evoke Pharma's EVK-001 Showed No QT Prolongation in Thorough ECG (TQT) Study investment picks
2014/10/22
HOUSTON , Oct.
Sign-up for Evolution Petroleum Announces 1st Quarter Earnings Release Conference Call investment picks
2014/10/7
HOUSTON , Oct.
Sign-up for Evolution Petroleum Declares Cash Dividend on 8.5% Series A Preferred Stock investment picks
2014/11/3
HOUSTON , Nov.
Sign-up for Evolution Petroleum Declares Cash Dividend on 8.5% Series A Preferred Stock investment picks
2014/12/2
HOUSTON , Dec.
Sign-up for Evolution Petroleum Declares Cash Dividend on 8.5% Series A Preferred Stock investment picks
2014/9/18
HOUSTON , Sept.
Sign-up for Evolution Petroleum to Present at IPAA OGIS San Francisco Conference investment picks
2014/11/19
HOUSTON , Nov.
Sign-up for Evolution Petroleum Updates Capital Spending Plans investment picks
2014/9/26
Evolution1 – a WEX Company – a leading provider of cloud-based, consumer-directed healthcare and defined contribution payments and technology solutions – has unveiled its all-new 2015 Open Enrollment Kickstart site .
Sign-up for Evolution1 – a WEX Company Continues Marketing Leadership with Kickstart Open Enrollment Kit investment picks
http://media.marketwire.com/attachments/201211/102974_EvolvinglogoR.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1156272&ProfileId=051205&sourceType=1 ENGLEWOOD, CO --
Sign-up for Evolving Systems Reports Third Quarter 2014 Financial Results investment picks
http://media.marketwire.com/attachments/201211/102974_EvolvinglogoR.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1153883&ProfileId=051205&sourceType=1 ENGLEWOOD, CO --
Sign-up for Evolving Systems Sets Date for 2014 Third Quarter Results News Release and Conference Call investment picks
Evolving the way Nectar points are issued in Sainsbury's Canada NewsWire MONTREAL , Oct.
Sign-up for Evolving the way Nectar points are issued in Sainsbury's investment picks
2014/12/2
Parties have entered into exclusive negotiations and expect to sign the transaction in H1 2015 Goal to improve innovation effectiveness in drug discovery and pre-clinical development Building pipeline focused on oncology I nnovation bridge from academia to Pharma Long-term outsourcing collaboration on key drug discovery services for Sanofi; Evotec will acquire Sanofi's scientific operations in Toulouse Creation of Evotec's European compound management facility and service Pioneering open innovation programme with Sanofi and Evotec offering their combined approx.
Sign-up for Evotec and Sanofi Enter Into Exclusive Negotiations for a Major Multi-Component Strategic Collaboration investment picks
2014/12/8
Norwegian information-technology company Evry ASA said Monday it has received a recommended 4.27 billion kroner ($597.5 million) takeover offer from Lyngen Bidco AS, a company indirectly owned by private-equity funds advised by Apax Partners LLP.
Sign-up for Evry Receives Takeover Bid From Lyngen Bidco investment picks
By James Sterngold David Riley, a former executive at Foundry Network Inc., a computer equipment company, was found guilty Thursday in Federal District Court in Manhattan on three of four counts for his involvement in an insider-trading scheme in 2008.
Sign-up for Ex-Foundry Network executive guilty of insider trading investment picks
BURLINGTON, Mass., Oct.
Sign-up for Exa Appoints Michelle Woods Burnett as Vice President of Human Resources investment picks
Reports Strong Year-over-Year Revenue and License Growth Expects Business Momentum to Continue BURLINGTON, Mass., Dec.
Sign-up for Exa Reports Third Quarter Fiscal 2015 Financial Results investment picks
MDVIP , the leader in personalized preventive medicine with a nationwide network of over 750 affiliated primary care physicians, announced today that Cologuard ® , the first and only Food and Drug Administration (FDA) approved , noninvasive stool DNA screening test for colorectal cancer will now be available by prescription through their physicians.
Sign-up for Exact Sciences Announces MDVIP As The First Network of Personalized Healthcare Physicians To Offer Cologuard, A New Noninvasive Stool-Based DNA Test For Colon Cancer investment picks
Exact Sciences Corp.
Sign-up for Exact Sciences Announces Mercy Hospital St. Louis Now Offering Cologuard® investment picks
Exact Sciences Corp.
Sign-up for Exact Sciences Announces Meriter-UnityPoint Health Now Offering Cologuard® investment picks
Exact Sciences Corp.
Sign-up for Exact Sciences Reports Third-Quarter 2014 Financial Results investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Evoke Pharma Announces the Completion of Enrollment in Its Thorough ECG Study for EVK-001 to Exact Sciences Reports Third-Quarter 2014 Financial Results
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent